ClinicalTrials.gov
ClinicalTrials.gov Menu

Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01568645
Recruitment Status : Withdrawn
First Posted : April 2, 2012
Last Update Posted : July 7, 2017
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )